Ask AI
CheckMate 8HW Update
CheckMate 8HW: Expanded Analyses in Patients With Centrally Confirmed MSI-H/dMMR mCRC From the Phase III Trial of Nivolumab + Ipilimumab vs Nivolumab or Chemotherapy

Released: June 09, 2025

Expiration: December 08, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: June 09, 2025

Expiration: December 08, 2025